Catecholamines and opioid peptides in human phaeochromocytomas

Area of Science:

• Endocrinology
• Neuroscience
• Oncology

Background:

• Phaeochromocytomas (Phs) are neuroendocrine tumors originating from chromaffin cells, primarily secreting catecholamines (CAs).
• The co-secretion and regulation of CAs and opioid peptides, such as methionine-enkephalin (Met-enk), in Phs are not fully understood.

Purpose of the Study:

• To investigate the tissue content and secretion patterns of CAs and Met-enk in human phaeochromocytomas.
• To explore the modulatory effects of opioid peptides on catecholamine secretion from cultured Ph cells.

Main Methods:

• Analysis of tissue catecholamine (CA) and methionine-enkephalin-like immunoreactivity (Met-enk) content in 8 patients with phaeochromocytomas (Phs).
• Culture of Ph cells from 6 patients to examine the secretion of CAs and Met-enk stimulated by nicotine.
• Assessment of the inhibitory effects of Met-enk, FK33-824 (a Met-enkephalin analogue), and dynorphin 1-13 on nicotine-evoked CA secretion.

Main Results:

• Tissue CA and Met-enk content varied among patients; medullary Phs had higher Met-enk than extramedullary ones.
• Nicotine stimulated simultaneous CA and Met-enk secretion, but Met-enk secretion was not proportional to CA levels.
• Met-enk, FK, and Dyn significantly suppressed nicotine-induced CA secretion, with varying potencies (IC50 values).

Conclusions:

• Human phaeochromocytomas exhibit heterogeneity in the storage and secretion of catecholamines and opioid peptides.
• Opioid peptides play a regulatory role in modulating catecholamine release from phaeochromocytoma cells.